Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?

Med Mal Infect. 2018 Jun;48(4):294-297. doi: 10.1016/j.medmal.2018.01.003. Epub 2018 Feb 3.
No abstract available

Keywords: Aspergillose cérébrale; Cerebral aspergillosis; Chronic lymphocytic leukemia; Ibrutinib; Leucémie lymphoïde chronique.

Publication types

  • Case Reports

MeSH terms

  • Adenine / analogs & derivatives
  • Aged
  • Brain Diseases / chemically induced*
  • Brain Diseases / microbiology*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Male
  • Neuroaspergillosis / chemically induced*
  • Opportunistic Infections / chemically induced*
  • Piperidines
  • Pyrazoles / adverse effects*
  • Pyrazoles / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use

Substances

  • Piperidines
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Adenine